Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,534.1
-11.4 (-0.45%)

 

  • STI Straits Times Index
    2,534.1
    -11.4 (-0.45%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,567.9
    -3.8 (-0.24%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,821.4
    444.0 (1.82%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,340.3
    -39.0 (-1.15%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,750.2
    420.3 (1.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,192.4
    34.6 (0.67%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,058.1M
  • Value: 1,231.7M
  • Rise: 144
  • Fall: 182
  • Unch: 483

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.019+0.002
Oceanus^0.008-
ThaiBev0.605-
ISDN0.430+0.035
Polaris0.002-0.001
Intl Cement0.048+0.023
Keppel Corp4.830-0.570
Genting Sing0.675-0.005
Singtel2.350-0.030
Acromec0.166+0.079

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AKOUOS INC AKOUOS
Updated on 10 Aug 2020 (End of trading day)
Last (USD): 20.610 Change: +0.050 High: 21.634 Remarks: -
Change (%): +0.24 Low: 20.430
Open 20.600 Yesterday's Close 20.56
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 321,967 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.79248 Trailing EPS (USD) e -0.79248 NAV (USD) b -1.3272
PE a - Trailing PE f - Price / NAV b -15.5289
Dividend (USD) d - Cash In Hand (USD) g 3.6997 Issued & Paid-up Shares c 32,481,700
Dividend Yield (%) d - Price / Cash In Hand g 5.571 Treasury Shares h -
Market Cap (M) 669.448 Enterprise Value (M) 727.046
Piotroski F Score 2 Exchange Code AKUS Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 54.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 26 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 24 Jun 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AKOUOS INC NASDAQ 669.448 - - -15.5289 -
Industry Biotechnology NASDAQ 2,862.687 442.562 6455.431 7.3747 0.649
Local Peer AMGEN INC NASDAQ 139,494.740 17.788 19.111 13.0871 2.459
Local Peer GILEAD SCIENCES INC NASDAQ 85,892.357 15.947 - 4.7647 3.714
Local Peer VERTEX PHARMACEUTICAL NASDAQ 69,995.297 59.479 33.639 9.3088 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 64,711.852 30.585 21.690 7.1446 -
Local Peer ILLUMINA INC NASDAQ 51,589.100 51.486 74.953 11.3834 -
Local Peer BIOGEN INC NASDAQ 47,535.061 8.073 8.020 4.2034 -
Local Peer MODERNA INC NASDAQ 28,414.210 - - 9.5013 -
Local Peer SEATTLE GENETICS INC NASDAQ 27,439.327 - - 15.1258 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,329.345 9.287 26.391 2.1285 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 21,444.638 - 175.405 6.6255 -
Local Peer INCYTE CORPORATION NASDAQ 20,627.690 46.157 - 8.7979 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 18,849.099 - - - -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ALLOVIR INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), XENCOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), VERACYTE INC (NASDAQ), VAXCYTE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), EPIZYME INC (NASDAQ), CORTEXYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ARVINAS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), RETROPHIN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), NKARTA INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PASSAGE BIO INC (NASDAQ), OMEROS CORP (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AGENUS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), GERON CORP (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ARDELYX INC (NASDAQ), ATHERSYS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), ANAPTYSBIO INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), IVERIC BIO INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), MERUS B V (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NEXTCURE INC (NASDAQ), CHIASMA INC (NASDAQ), TREVENA INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), VERASTEM INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), XOMA CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), EQUILLIUM INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), LUMOS PHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), RECRO PHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ARAVIVE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), RESTORBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), COHBAR INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SOLIGENIX INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ADVAXIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 126,915.776 47.305 43.813 14.6750 0.949
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer WUXI BIO HKEx 219,594.926 191.024 191.024 15.3557 -
Global Peer SINO BIOPHARM HKEx 175,703.906 57.247 57.770 5.0714 0.570
Global Peer BEIGENE HKEx 149,674.975 - - 7.6141 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 6,890.293 126.428 40.460 5.7476 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 30,591.600 - - 10.2561 -
Global Peer 3SBIO HKEx 22,968.256 20.803 20.802 2.1333 -
Global Peer HAOHAI BIOTEC HKEx 18,220.033 43.336 43.336 3.0977 0.748
Other Global Peers VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), DPHARMA (Bursa), LEE'S PHARM (HKEx), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), IBIO INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), PFENEX INC (NYSE American), IMUGENE LIMITED (ASX), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), UNI-BIO GROUP (HKEx), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ANTEOTECH LIMITED (ASX), MEMPHASYS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), IMMUTEP LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), GENETIC TECHNOLOGIES (ASX), BIOTRON (ASX), ORAGENICS INC (NYSE American), CT ENTERPRISE (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIOSINO BIO-TEC (HKEx), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), REGENEUS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), HAO WEN H-NEW (HKEx), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), HAO WEN H-OLD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.100
+0.49 %
10 Days -+0.930
+4.73 %
20 Days --1.010
-4.67 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 19.000 - 24.080 Change From 1 Year Low +1.610 % Change From 1 Year Low (%) +8.47
Change From 1 Year High -3.470 % Change From 1 Year High (%) -14.41
2 Years Range 19.000 - 24.080 Change From 2 Years Low +1.610 % Change From 2 Years Low (%) +8.47
Change From 2 Years High -3.470 % Change From 2 Years High (%) -14.41
5 Years Range 19.000 - 24.080 Change From 5 Years Low +1.610 % Change From 5 Years Low (%) +8.47
Change From 5 Years High -3.470 % Change From 5 Years High (%) -14.41
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Akouos, Inc. engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna in 2017 and is headquartered in Boston, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
10 Aug 2020 20.600 21.634 20.430 20.610 321,967 -
07 Aug 2020 20.480 21.750 20.020 20.560 104,352 -
06 Aug 2020 21.420 21.590 20.320 20.330 72,227 -
05 Aug 2020 20.420 21.455 20.320 21.150 59,489 -
04 Aug 2020 20.140 20.985 19.560 20.510 113,082 -
03 Aug 2020 19.520 21.080 19.500 20.340 111,256 -
31 Jul 2020 19.850 20.225 19.140 19.550 193,418 -
30 Jul 2020 20.310 20.500 19.010 19.820 49,151 -
29 Jul 2020 19.990 20.800 19.710 20.300 109,643 -
28 Jul 2020 19.890 20.654 19.660 19.680 65,009 -
27 Jul 2020 20.240 20.600 19.500 19.990 84,811 -
24 Jul 2020 20.100 20.270 19.000 19.300 126,749 -
23 Jul 2020 20.020 20.600 19.497 20.040 43,334 -
22 Jul 2020 21.750 22.075 19.000 19.770 113,492 -
21 Jul 2020 21.480 22.490 21.480 21.780 136,781 -
20 Jul 2020 21.010 22.310 20.511 21.170 112,057 -
17 Jul 2020 21.020 21.853 20.900 21.120 23,673 -
16 Jul 2020 21.600 21.600 20.249 20.720 151,528 -
15 Jul 2020 21.980 22.357 21.320 21.700 85,760 -
14 Jul 2020 22.090 22.551 21.250 21.620 176,433 -
13 Jul 2020 22.600 23.246 21.990 22.490 147,427 -
10 Jul 2020 22.250 22.600 21.815 22.300 238,339 -
Summary
Current 2 Weeks
(28 Jul 2020 to 10 Aug 2020)
19.890 21.750 19.010 20.610 1,199,594 -
Previous 2 Weeks
(14 Jul 2020 to 27 Jul 2020)
22.090 22.551 19.010 19.990 1,054,618 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.